A citation-based method for searching scientific literature

S Bendifallah, N Chabbert-Buffet, N Maurin, J Chopier, M Antoine, C Bezu, S Uzan, R Rouzier. Anticancer Res 2012
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer.
Keiichiro Tada, Akiko Ogiya, Kiyomi Kimura, Hidetomo Morizono, Kotaro Iijima, Yumi Miyagi, Seiichiro Nishimura, Masujiro Makita, Rie Horii, Futoshi Akiyama,[...]. World J Surg Oncol 2010
20
100

What is the predictor for invasion in non-palpable breast cancer with microcalcifications?
Seiichiro Nishimura, Kaoru Takahashi, Naoya Gomi, Keiichiro Tada, Masujiro Makita, Takashi Tada, Takuji Iwase, Masataka Yoshimoto, Futoshi Akiyama, Goi Sakamoto,[...]. Breast Cancer 2004
6
100

Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Laura Chin-Lenn, Lloyd A Mack, Walley Temple, William Cherniak, Robert R Quinn, Pietro Ravani, Adriane M Lewin, May Lynn Quan. Ann Surg Oncol 2014
27
100

Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
C E Cox, S Pendas, J M Cox, E Joseph, A R Shons, T Yeatman, N N Ku, G H Lyman, C Berman, F Haddad,[...]. Ann Surg 1998
503
100

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Robert E Mansel, Lesley Fallowfield, Mark Kissin, Amit Goyal, Robert G Newcombe, J Michael Dixon, Constantinos Yiangou, Kieran Horgan, Nigel Bundred, Ian Monypenny,[...]. J Natl Cancer Inst 2006
100


Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
239
100

Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.
Min Yi, Savitri Krishnamurthy, Henry M Kuerer, Funda Meric-Bernstam, Isabelle Bedrosian, Merrick I Ross, Frederick C Ames, Anthony Lucci, Rosa F Hwang, Kelly K Hunt. Am J Surg 2008
47
100

Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
Francisco J Dominguez, Mehra Golshan, Dalliah M Black, Kevin S Hughes, Michele A Gadd, Roger Christian, Beth-Ann Lesnikoski, Michelle Specht, James Michaelson, Barbara L Smith. Ann Surg Oncol 2008
38
100

18
100


National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.
Carmen J Allegra, Denise R Aberle, Pamela Ganschow, Stephen M Hahn, Clara N Lee, Sandra Millon-Underwood, Malcolm C Pike, Susan D Reed, Audrey F Saftlas, Susan A Scarvalone,[...]. J Natl Cancer Inst 2010
153
100


Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
209
100

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast.
M A J de Roos, B van der Vegt, J L Peterse, C Patriarca, J de Vries, G H de Bock, J Wesseling. Histopathology 2007
21
100

Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
Sangjun Lee, Sheila Stewart, Iris Nagtegaal, Jingqin Luo, Yun Wu, Graham Colditz, Dan Medina, D Craig Allred. Cancer Res 2012
110
100

Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.
Umberto Veronesi, Giuseppe Viale, Giovanni Paganelli, Stefano Zurrida, Alberto Luini, Viviana Galimberti, Paolo Veronesi, Mattia Intra, Patrick Maisonneuve, Francesca Zucca,[...]. Ann Surg 2010
341
100

Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Jensen C C Tan, David R McCready, Alexandra M Easson, Wey L Leong. Ann Surg Oncol 2007
46
100


Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
Christine Tunon-de-Lara, Sylvia Giard, Max Buttarelli, Jérome Blanchot, Jean-Marc Classe, Marc Baron, Brice Monnier, Gilles Houvenaeghel. Breast J 2008
31
100


American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, Karen L Hagerty, D Craig Allred, Richard J Cote, Mitchell Dowsett, Patrick L Fitzgibbons, Wedad M Hanna, Amy Langer,[...]. J Clin Oncol 2007
100

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast.
Amanda Arantes Perez, Rafael Malagoli Rocha, Débora Balabram, Átila da Silva Souza, Helenice Gobbi. Clinics (Sao Paulo) 2013
5
100

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
236
100

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra,[...]. Lancet Oncol 2013
734
100

Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.
Jean-François Rodier, Michel Velten, Marc Wilt, Pierre Martel, Gwanaël Ferron, Véronique Vaini-Elies, Hervé Mignotte, Alain Brémond, Jean-Marc Classe, François Dravet,[...]. J Clin Oncol 2007
82
100

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
36
100

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, Karla V Ballman, Peter D Beitsch, Pat W Whitworth, Peter W Blumencranz, A Marilyn Leitch, Sukamal Saha, Linda M McCall, Monica Morrow. JAMA 2011
100

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
D C Allred, G M Clark, R Molina, A K Tandon, S J Schnitt, K W Gilchrist, C K Osborne, D C Tormey, W L McGuire. Hum Pathol 1992
357
100

Trends in the treatment of ductal carcinoma in situ of the breast.
Nancy N Baxter, Beth A Virnig, Sara B Durham, Todd M Tuttle. J Natl Cancer Inst 2004
255
100


Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
T J Meretoja, P S Heikkilä, K Salmenkivi, M H K Leidenius. Ann Surg Oncol 2012
22
100

Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Nehmat Houssami, Daniela Ambrogetti, M Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P Mamounas, Stefano Ciatto. Ann Surg Oncol 2011
30
100

Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer.
Gilles Houvenaeghel, Claude Nos, Hervé Mignotte, Jean Marc Classe, Sylvie Giard, Philippe Rouanet, Frédérique Penault Lorca, Jocelyne Jacquemier, Valérie Jeanne Bardou. J Clin Oncol 2006
107
100

Underestimation of invasive lesions in patients with ductal carcinoma in situ of the breast diagnosed by ultrasound-guided biopsy: a comparison between patients with and without HER2/neu overexpression.
Wei-Chou Chang, Hsian-He Hsu, Jyh-Cherng Yu, Kai-Hsiung Ko, Yi-Jen Peng, Ho-Jui Tung, Tsun-Hou Chang, Giu-Cheng Hsu. Eur J Radiol 2014
12
100

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park,[...]. Breast 2012
46
100


Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
Cathal J Moran, Malcolm R Kell, Fidelma L Flanagan, Maria Kennedy, Thomas F Gorey, Michael J Kerin. Am J Surg 2007
36
100

Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
M Leidenius, K Salmenkivi, K von Smitten, P Heikkilä. J Surg Oncol 2006
33
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.